3.13.26
7 min. Read

Details: Vida Health’s brief GLP-1 rollout in Mass. Plus: CMS says Freespira not DME

Issue 365
Welcome back to E&O: a paying subscribers-only weekly newsletter focused on three areas of health tech: FDA-regulated software devices, digital health as an employee benefit, and national virtual clinics.

GLP-1, GLP-lost

• • •

In this issue of E&O

  • Numbers: Vida Health helps de-prescribe GLP-1s for Massachusetts state employees
  • Click Therapeutics' De Novo clearance summary document is finally up
  • Pricing for CirrusMD (Quantum

Sign-up for the newsletter for access.

It's a good one, too.

This article is for Exits & Outcomes subscribers only. Subscribe now to get the weekly newsletter. Enter your email below to subscribe today!

×

Newsletters

Filter by
All Selling to Employers Prescription Digital Therapeutics National Virtual Clinics
    415 articles
  • First
  • Previous
    • 1 of 42
  • Next
  • Last
Six years of Oura’s financials: Revenue, profits, marketing spend and more
5.22.26
4 min. Read
ACCESS Model’s first dropout? Plus: A few new participants
5.08.26
6 min. Read
Are these Utah’s next four AI experiments? Plus: More on the Utah Pharmacy Board’s questions about Doctronic
4.17.26
9 min. Read
Emails show how Doctronic’s AI pilot blindsided Utah’s Medical Board
4.10.26
13 min. Read
Quiet funding rounds. Plus: Digital health-related clinical trial round-ups
3.20.26
5 min. Read
ACCESS Model’s shockingly low payments. DMHT Rx count.
2.13.26
7 min. Read
HLTH acquisition price. Estimating Pomelo Care pricing, revenue, and more
1.09.26
7 min. Read
CMS to pay for ADHD DTx. More PFS notes. Two FDA De Novos.
11.07.25
6 min. Read
Pricing for Sword Health, Hinge Health, Joint Academy in the UK.
10.31.25
7 min. Read
Spring, Slingshot AI, Click and others write FDA about GenAI. Big Health board departs.
10.24.25
7 min. Read
  • First
  • Previous
    • 1 of 42
  • Next
  • Last